Should investors be concerned about Braskem S.A. ADR (BAK)?

While Braskem S.A. ADR has underperformed by -3.93%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BAK fell by -46.50%, with highs and lows ranging from $7.71 to $2.85, whereas the simple moving average fell by -22.79% in the last 200 days.

On March 03, 2025, Scotiabank Downgraded Braskem S.A. ADR (NYSE: BAK) to Sector Perform. A report published by UBS on September 18, 2024, Upgraded its rating to ‘Buy’ for BAK. JP Morgan July 05, 2023d its ‘Overweight’ rating to ‘Neutral’ for BAK, as published in its report on July 05, 2023. UBS also rated the stock as ‘Neutral’.

Analysis of Braskem S.A. ADR (BAK)

Further, the quarter-over-quarter decrease in sales is -8.05%, showing a negative trend in the upcoming months.

To gain a thorough understanding of Braskem S.A. ADR’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -8638.28% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.76, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

It is also very valuable to look at average volume as an indicator of volatility for a stock, and BAK is recording an average volume of 920.07K. On a monthly basis, the volatility of the stock is set at 3.46%, whereas on a weekly basis, it is put at 3.39%, with a loss of -3.93% over the past seven days. Furthermore, long-term investors anticipate a median target price of $5.52, showing growth from the present price of $3.67, which can serve as yet another indication of whether BAK is worth investing in or should be passed over.

How Do You Analyze Braskem S.A. ADR Shares?

The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As opposed to executive stock, institutional ownership accounts for 4.81% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

BAK shares are owned by institutional investors to the tune of 4.81% at present.

Hot this week

What to expect from CRWD’s earnings report this quarter?

In the current trading session, Crowdstrike Holdings Inc's (CRWD)...

Predicting Inmode Ltd’s (INMD) earnings for the current quarter

Inmode Ltd (INMD)'s stock is trading at $15.46 at...

BKD’s Q2 earnings predictions: What the experts say

Brookdale Senior Living Inc (BKD)'s stock has witnessed a...

How will IGC Pharma Inc’s (IGC) earnings compare to estimates this quarter?

Currently, IGC Pharma Inc's (IGC) stock is trading at...

DVN’s Q2 earnings estimates: What investors need to know

In the current trading session, Devon Energy Corp's (DVN)...

Topics

What to expect from CRWD’s earnings report this quarter?

In the current trading session, Crowdstrike Holdings Inc's (CRWD)...

Predicting Inmode Ltd’s (INMD) earnings for the current quarter

Inmode Ltd (INMD)'s stock is trading at $15.46 at...

BKD’s Q2 earnings predictions: What the experts say

Brookdale Senior Living Inc (BKD)'s stock has witnessed a...

How will IGC Pharma Inc’s (IGC) earnings compare to estimates this quarter?

Currently, IGC Pharma Inc's (IGC) stock is trading at...

DVN’s Q2 earnings estimates: What investors need to know

In the current trading session, Devon Energy Corp's (DVN)...

Can Frontline Plc (FRO) meet market expectations this quarter?

Frontline Plc (FRO)'s stock is trading at $18.27 at...

BBIO’s earnings forecast for the current quarter

BridgeBio Pharma Inc (BBIO)'s stock has witnessed a price...

Breaking down XERS’s current quarter earnings estimates

Currently, Xeris Biopharma Holdings Inc's (XERS) stock is trading...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.